Xanthohumol modulates the expression of osteoclast-specific genes during osteoclastogenesis in RAW264.7 cells

Food and Chemical Toxicology

Volumn 62, Issue , 2013, Pages 99-106

  Suh, Kwang Sik ^a   Rhee, Sang Youl ^b   Kim, Young Seol ^b   Lee, Young Soon ^c   Choi, Eun Mi ^c  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Osteoclastogenesis; RANKL; Signaling pathway; Xanthohumol

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CARBONATE DEHYDRATASE II; CATHEPSIN K; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; XANTHOHUMOL; CHLORIDE CHANNEL; CLCN7 PROTEIN, MOUSE; CTSK PROTEIN, MOUSE; FLAVONOID; GAB2 PROTEIN, MOUSE; MEMBRANE PROTEIN; NFATC1 PROTEIN, MOUSE; OSTM1 PROTEIN, MOUSE; PHOSPHOPROTEIN; PROPIOPHENONE DERIVATIVE; TNFSF11 PROTEIN, MOUSE; TRANSCRIPTION FACTOR NFAT;

AKT GENE; ANIMAL CELL; ARTHRITIS; ARTICLE; C SRC GENE; CARBONIC ANHYDRASE II GENE; CATHEPSIN K GENE; CELL STRAIN RAW264.7; CLCN7 GENE; CONTROLLED STUDY; DRUG INDICATION; DRUG MECHANISM; ERK GENE; GAB2 GENE; GENE; GENE EXPRESSION REGULATION; INHIBITION KINETICS; MACROPHAGE CULTURE; MMP 9 GENE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; OSTM1 GENE; PERIODONTITIS; PI3K GENE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TCIRG GENE; TRAF6 GENE; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; ONCOGENE; OSTEOCLAST; PHYSIOLOGY;

ANIMALS; CARBONIC ANHYDRASE II; CATHEPSIN K; CELL LINE; CHLORIDE CHANNELS; FLAVONOIDS; GENE EXPRESSION REGULATION; GENES, FOS; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PROPIOPHENONES; RANK LIGAND; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84883754144     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.08.047     Document Type: Article

References (42)

1. Albini A., Dell'Eva R., Vené R., Ferrari N., Buhler D.R., Noonan D.M. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J. 2006, 20:527-529.
2. Angel N.Z., Walsh N., Forwood M.R., Ostrowski M.C., Cassady A.I., Hume D.A. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J. Bone Miner. Res. 2000, 15:103-110.
3. Baron R., Ravesloot J.H., Neff L., Chakraborty M., Chatterjee D., Lomri A. Cellular and Molecular Biology of Bone 1993, 445-495. Academic, San Diego. M. Noda (Ed.).
4. Batt D.G., Goodman R., Jones D.G., Kerr J.S., Mantegna L.R., McAllister C., Newton R.C., Nurnberg S., Welch P.K., Covington M.B. 2'-Substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis. J. Med. Chem. 1993, 36:1434-1442.
5. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol. 2003, 41:631-636.
6. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
7. Chalhoub N., Benachenhou N., Rajapurohitam V., Pata M., Ferron M., Frattini A. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat. Med. 2003, 9:399-406.
8. David J.P., Sabapathy K., Hoffmann O., Idarraga M.H., Wagner E.F. Jnk1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 2002, 115:4317-4325.
9. Effenberger K.E., Johnsen S.A., Monroe D.G., Spelsberg T.C., Westendorf J.J. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J. Steroid Biochem. Mol. Biol. 2005, 96:387-399.
10. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 2000, 25:343-346.
11. Henriksen K., Gram J., Schaller S., Dahl B.H., Dziegiel M.H., Bollerslev J. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am. J. Pathol. 2004, 164:1537-1545.
12. Heyerick A., Vervarcke S., Depypere H.T., Bracke M.E., De Keukeleire D. A first prospective, randomized, doubleblind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006, 54:164-175.
13. Hotokezaka H., Sakai E., Kanaoka K., Saito K., Matsuo K., Kitaura H., Yoshida N., Nakayama K. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J. Biol. Chem. 2002, 277:47366-47372.
14. Kassenbrock C.K., Hunter S., Garl P., Johnson G.L., Anderson S.M. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J. Biol. Chem. 2002, 277:24967-24975.
15. Kim N., Kadono Y., Takami M., Lee J., Lee S.H., Okada F. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 2005, 202:589-595.
16. Kusano K., Miyaura C., Inada M., Tamura T., Ito A., Nagase H. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 1998, 139:1338-1345.
17. Lange P.F., Wartosch L., Jentsch T.J., Fuhrmann J.C. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006, 440:220-223.
18. Lee Z.H., Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 2003, 305:211-214.
19. Li X., Udagawa N., Itoh K., Suda K., Murase Y., Nishihara T. P38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 2002, 143:3105-3113.
20. Liu B., Yu S.F., Li T.J. Multinucleated giant cells in various forms of giant-cell-containing lesions of the jaws express features of osteoclasts. J. Oral Pathol. Med. 2003, 32:367-375.
21. Loomer P.M., Ellen R.P., Tenenbaum H.C. Osteogenic and osteoclastic cell interaction: development of a co-culture system. Cell Tissue Res. 1998, 294:99-108.
22. Macdonald R., Bingham S., Bond B.C., Parsons A.A., Philpott K.L. Determination of changes in mRNA expression in a rat model of neuropathic pain by TaqmanE quantitative RT-PCR. Mol. Brain Res. 2001, 90:48-56.
23. Miyazaki T., Katagiri H., Kanegae Y., Takayanagi H., Sawada Y., Yamamoto A. Reciprocal role of ERK and NF-kB pathways in survival and activation of osteoclasts. J. Cell Biol. 2000, 148:333-342.
24. Miyazaki T., Neff L., Tanaka S., Horne W.C., Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 2003, 160:709-718.
25. Miyazaki T., Sanjay A., Neff L., Tanaka S., Horne W.C., Baron R. Src kinase activity is essential for osteoclast function. J. Biol. Chem. 2004, 279:17660-17666.
26. Monje P., Hernández-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 2005, 280:35081-35084.
27. Nikolic D., Li Y., Chadwick L.R., Pauli G.F., van Breemen R.B. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 2005, 40:289-299.
28. +)-ATPases-nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 2002, 3:94-103.
29. Nishi Y., Atley L., Eyre D.E., Edelson J.G., Superti-Furga A., Yasuda T. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J. Bone Miner. Res. 1999, 14:1902-1908.
30. Nookkanda A., Frank N., Steiner F., Ellinger R., Schneider B., Gerhäuser C., Becker H. Xanthohumol metabolites in faeces of rats. Phytochemistry 2004, 65:561-570.
31. Reuter S., Prasad S., Phromnoi K., Kannappan R., Yadav V.R., Aggarwal B.B. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway. Mol. Cancer Res. 2010, 8:1425-1436.
32. Rousselle A.V., Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 2002, 30:533-540.
33. Song I., Kim J.H., Kim K., Jin H.M., Youn B.U., Kim N. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett. 2009, 583:2435-2440.
34. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
35. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
36. Tobe H., Muraki Y., Kitamura K., Komiyama O., Sato Y., Sugioka T. Bone resorption inhibitors from hop extract. Biosci. Biotechnol. Biochem. 1997, 61:158-159.
37. Uchiyama S., Yamaguchi M. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J. Cell Biochem. 2007, 101:529-542.
38. Väänänen H.K., Laitala-Leinonen T. Osteoclast lineage and function. Arch. Biochem. Biophys. 2008, 473:132-138.
39. Viereck V., Gründker C., Blaschke S., Siggelkow H., Emons G., Hofbauer L.C. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J. Cell Biochem. 2002, 84:725-735.
40. Woellmer W. Über die Bitterstoffe des Hopfens. Chem. Ber. 1916, 49:780-794.
41. Wong B.R., Besser D., Kim N., Arron J.R., Vologodskaia M., Hanafusa H. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 1999, 4:1041-1049.
42. Yadav V.R., Prasad S., Sung B., Aggarwal B.B. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int. Immunopharmacol. 2011, 11:295-309.